A5065661141- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Radiomics and Machine Learning in Medical Imaging
- Urologic and reproductive health conditions
- Bladder and Urothelial Cancer Treatments
- AI in cancer detection
- MRI in cancer diagnosis
- Colorectal Cancer Surgical Treatments
- Urinary Bladder and Prostate Research
- Renal cell carcinoma treatment
- Artificial Intelligence in Healthcare
- Advanced Neural Network Applications
- Pediatric Urology and Nephrology Studies
- Colorectal Cancer Screening and Detection
- Advanced Radiotherapy Techniques
- Medical Imaging and Analysis
- Cancer Genomics and Diagnostics
- Radiation Dose and Imaging
- Climate Change and Health Impacts
- Sexual function and dysfunction studies
- Artificial Intelligence in Healthcare and Education
- Hormonal and reproductive studies
- Drug-Induced Ocular Toxicity
- Ocular Oncology and Treatments
- Head and Neck Cancer Studies
University of Southern California
2020-2025
Kyoto Prefectural University of Medicine
2017-2025
Yale University
2023
New York University
2023
Cleveland Clinic
2023
Prostate Cancer Foundation
2022
Nishijin Hospital
2018
National Archives and Records Administration
2016
Hiroshima City Asa Citizens Hospital
2009
We report outcomes of hemigland high intensity focused ultrasound ablation as primary treatment for localized prostate cancer in the United States.
Artificial intelligence (AI) is here to stay and will change health care as we know it. The availability of big data the increasing numbers AI algorithms approved by US Food Drug Administration together help in improving quality for patients overcoming human fatigue barriers. In oncology practice, providers rely on interpretation radiologists when making clinical decisions; however, there considerable variability among readers, particular prostate imaging. represents an emerging solution...
Several reports are available regarding the treatment decision regret of patients receiving conventional treatments for localized prostate cancer (PCa); yet data on undergoing focal therapy (FT) sparse.To evaluate satisfaction and among who underwent FT PCa with high-intensity focused ultrasound (HIFU) or cryoablation (CRYO).We identified consecutive HIFU CRYO as primary at three US institutions. A survey validated questionnaires, including five-question Decision Regret Scale (DRS),...
Purpose: To create a nomogram to predict the absence of clinically significant prostate cancer (CSPCa) in males with non-suspicion multiparametric magnetic resonance imaging (mpMRI) undergoing biopsy (PBx). Materials and Methods: We identified consecutive patients who underwent 3T mpMRI followed by PBx for suspicion PCa or surveillance follow-up. All had Prostate Imaging Reporting Data System score 1-2 (negative mpMRI). CSPCa was defined as Grade Group ≥2. Multivariate logistic regression...
We evaluated the prostate cancer and clinically significant detection on systematic biopsy (SB), target (TB) alone combined SB TB in men with Prostate Imaging Reporting Data System™ (PI-RADS™) 5 lesion.From a prospectively maintained database, we identified consecutive patients PI-RADS lesion multiparametric magnetic resonance imaging. The underwent imaging followed by transrectal of 12-core SB. (Grade Group, GG ≥2) SB, SB+TB were determined for all accordingly to specific antigen density....
The objective of this study was to compare transperineal (TP) versus transrectal (TR) magnetic resonance imaging (MRI) and ultrasound (TRUS) fusion prostate biopsy (PBx). Consecutive men who underwent MRI followed by a systematic biopsy. Additional target biopsies were performed from Prostate Imaging Reporting & Data System (PIRADS) 3-5 lesions. Men TP PBx matched 1:2 with synchronous cohort undergoing TR PSA, volume (PV) PIRADS score. Endpoint the detection clinically significant cancer...
To develop a classification system for urine cytology with artificial intelligence (AI) using convolutional neural network algorithm that classifies cell images as negative (benign) or positive (atypical malignant).We collected 195 slides from consecutive patients histologically confirmed diagnosis of urothelial cancer (between January 2016 and December 2017). Two certified cytotechnologists independently evaluated labelled each slide; 4637 concordant diagnoses were selected, including 3128...
<title>Abstract</title> <bold>Objectives</bold>: To assess the valuability of MRI-determined tumor contact area as a predictive factor pathological extraprostatic extension in cT2N0M0 prostate cancer. <bold>Methods</bold>: Seventy-two cancer patients were retrospectively analyzed who received multiparametric MRI followed by robot-assisted laparoscopic prostatectomy primary treatment between February 2014 and April 2021. Patients excluded whose index lesion did not match specimen. was...
Abstract Objectives We aim to compare salvage robotic radical prostatectomy (sRRP) for recurrent prostate cancer (PCa) after primary radiation (RT) versus focal therapy (FT). Materials and Methods Patients who underwent sRRP following local PCa were identified. Perioperative findings functional/oncologic outcomes compared in RT FT groups. Results Overall, 112 patients included, with 84 receiving 28 as treatment. Median age PSA 68 years 5.4 ng/mL, respectively. There was one rectal injury the...
Objective To examine the safety and efficacy of microwave tissue coagulation (MTC) for prostate cancer assess its use in lesion‐targeted focal therapy a non‐clinical study clinical phase II trial. Methods In using Microtaze ® ‐AFM‐712 (Alfresa Pharma Corporation, Osaka, Japan) with an MTC needle, was performed transperineal approach to targeted canine prostatic under real‐time ultrasonography guidance. Using various output irradiation time combinations, surrounding tissues (rectum, bladder...
A TRUS-guided prostate biopsy (PBx) carries inherent risk of rectal bleeding, UTI, sepsis, and potentially under-detecting cancer (PCa) [1]. Although transperineal (TP) PBx has been recommended by some guidelines as a safer alternative, it is underperformed urologists because lack training, exposure, familiarity with the technique, burden special supplies (grids needle guides) [1-3]. Here, we describe our step-by-step technique outcomes 'double-freehand' TP MRI/TRUS fusion under local...